INDIANAPOLIS (WISH) - A worldwide diabetes epidemic has Indianapolis-based Eli Lilly Company expanding to meet the insulin needs of diabetics.
To do that, Lilly is building a new manufacturing plant on its Indianapolis Technology Center campus.
Insulin is the cornerstone of the Eli Lilly Company. It introduced the product to the U.S. market from Indianapolis in 1923.
In its new project, cartridges used to inject insulin with a specially made pen will be manufactured in Indianapolis. The need is clear, says Enrique Conterno, president of Lilly Diabetes.
"Last year, diabetes affected more than 350 million people world wide. By 2030, that figure is expected to rise to over 550 million people," he says.
The cartridges are already made at Lilly plants in Europe. The pens are already made in Indianapolis, so Lilly executives decided to bring the new cartridge technology to Indianapolis too.
"This is one of Lilly's most significant U.S.-based manufacturing investments in the last decade," said John Lechleiter, CEO and Chairman of Eli Lilly.
Spending $140 million, Lilly will expand its Indianapolis insulin manufacturing plant by 80,000 square feet. Construction will begin immediately and the local impact of the project will be felt immediately too, said Sean Seyferth, business manager of the International Brotherhood of Electrical Workers Local 481.
"The positive impact of this project will be felt immediately in the construction industry, by the more than 250 highly trained, skilled tradesman it will take to build this first of its kind facility in the United States," he said.
Construction is expected to be finished by March 2014. And when it's done, the local impact will continue, said Maria Crowe, President of Manufacturing Operations for Lilly.
"When the project is complete and the facility is operational, it will employ about 100 different kind of employees to manufacture insulin in this facility," she said.
Not all of the jobs will be new hires. Some will come from current Lilly operations in Indianapolis. But it's a $140 million reassurance that Lilly is committed to Indianapolis.
While the Indianapolis plant will be finished in 2014, it won't be up and running until 2015. That's because once built, it has to be approved by the FDA and other health oversight organizations worldwide. But before that, Lilly says it has four diabetes medicines in late stage development. Three of them will be ready to go to regulatory authorities next year.
?
Source: http://www.wishtv.com/dpp/news/local/marion_county/eli-lilly-plans-140m-indy-expansion
cat in the hat green eggs and ham wiz khalifa and amber rose oh the places you ll go blunt amendment justin bieber birthday read across america
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন